MedPath

A prospective study to evaluate clinical, neurophysiological and neuropsychological consequences of epilepsy surgery in patients with symptomatic focal epilepsy refractory to pharmacotherapy

Recruiting
Conditions
G40.2
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
Registration Number
DRKS00021602
Lead Sponsor
niversitätsklinikum Göttingen Klinik für Anästhesiologie und Klinik für Neurologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Medication refractory epilepsy (as of current Guidelines of the ILAE);
- Decision for resective epilepsy surgery based on an interdisciplinary case-conference

Exclusion Criteria

Idiopathic generalized epilepsy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Seizure frequency 12 and 24 months after resective epilepsy surgery
Secondary Outcome Measures
NameTimeMethod
Quality of life 3, 6, 12 and 24 months after resective epilepsy surgery; Neuropsychology 6, 12 and 24 months after resective epilepsy surgery; prognostic value of EEG for the success of epilepsy surgery; predictive value of diagnostic Tools in epilepsy surgery
© Copyright 2025. All Rights Reserved by MedPath